US 11453719
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
granted A61KA61K38/1774A61P
Quick answer
US patent 11453719 (Compositions and methods for treating cancer with anti-ROR1 immunotherapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/1774, A61P, A61P35/00